N Verses Capital, LLC Heron Therapeutics, Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 7,800 shares of HRTX stock, worth $14,586. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,800Holding current value
$14,586% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
198Shares Held
129MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$50 Million2.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$16.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$15.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.6MShares$14.2 Million0.05% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.1 Million58.47% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $222M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...